← Home
/
RIGEL PHARMACEUTICALS INC (RIGL)
Stock Analysis
RIGEL PHARMACEUTICALS INC (RIGL)
RIGL
RIGL · Market data
33.37
+2.80%
Updated: 2026-06-18 13:33 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 34.09. Holding above 31.10 keeps the current thesis intact.
✓
Fundamentals
Moderate / Positive
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
31.10
↗
Break Above
Confirmation improves above resistance.
34.09
🎯
Next Objective
Pattern-derived target if setup continues.
41.39
×
Thesis Break
Scenario weakens below invalidation.
Below 31.10
What's Driving RIGL?
📈 Technical recovery is improving
Momentum is Neutral. Watch 34.09 for confirmation and 31.10 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 31.10 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 31.10 and resistance around 34.39. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup. Pattern-based invalidation is near 24.20; losing that area would weaken the active formation considerably.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
💵 Revenue
58.82M
≈ Moderate
📈 Net Income
8.65M
↗ Positive
🧮 EPS (Basic)
0.47
↗ Positive
RIGEL PHARMACEUTICALS INC
Note: This is an algorithmic technical snapshot, not financial advice.